AADACL2, or Arylacetamide Deacetylase-Like 2, is a member of the serine hydrolase superfamily and is encoded by the gene AADACL2. This enzyme is involved in lipid metabolism, specifically in the hydrolysis of acetyl groups from arylacetamide substrates, which can modulate the activity of a variety of lipid signaling molecules. Through its deacetylation activity, AADACL2 influences the balance and availability of bioactive lipids, which play a crucial role in cellular signaling pathways.
The precise biological functions of AADACL2 are still being explored; however, it is known to be expressed in several human tissues, with higher levels found in the kidney and liver. This suggests a potential role in the metabolism and detoxification of drugs and xenobiotic compounds within these organs. Additionally, the enzyme's activity has been implicated in the metabolism of certain pharmaceutical agents, affecting their efficacy and pharmacokinetics.AADACL2's role in lipid metabolism also indicates a possible involvement in the pathophysiology of metabolic disorders. Lipid signaling molecules, such as those affected by AADACL2's enzymatic activity, are integral to processes like inflammation, cell proliferation, and apoptosis. Consequently, dysregulation of AADACL2 could potentially contribute to the development or progression of metabolic diseases, inflammatory conditions, and even cancer.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipase Inhibitor, THL | 96829-58-2 | sc-203108 | 50 mg | $52.00 | 7 | |
A lipase inhibitor, can alter lipid metabolism, potentially impacting enzymes like AADACL2 involved in lipid processing. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
A fibrate drug, known to modulate lipid metabolism, could indirectly affect AADACL2's role in lipid processing. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $66.00 $267.00 | 2 | |
Another fibrate medication, can influence lipid metabolism, potentially impacting AADACL2. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Influences lipid metabolism, potentially affecting enzymes involved in lipid processing, including AADACL2. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
A statin drug, used to lower cholesterol, might indirectly affect lipid metabolism enzymes including AADACL2. | ||||||
Rosuvastatin | 287714-41-4 | sc-481834 | 10 mg | $145.00 | 8 | |
Another statin, affects lipid metabolism, potentially impacting AADACL2. | ||||||
Ezetimibe | 163222-33-1 | sc-205690 sc-205690A | 25 mg 100 mg | $96.00 $241.00 | 12 | |
Inhibits the absorption of cholesterol in the intestine, potentially influencing lipid metabolism and enzymes like AADACL2. | ||||||
Linoleic Acid | 60-33-3 | sc-200788 sc-200788A sc-200788B sc-200788C | 100 mg 1 g 5 g 25 g | $34.00 $64.00 $166.00 $281.00 | 4 | |
A fatty acid known to influence lipid metabolism, could impact the activity of enzymes like AADACL2. | ||||||